Daiichi Life Insurance Co. Ltd. Acquires Shares of 46,183 The Allstate Corporation $ALL

Daiichi Life Insurance Co. Ltd. bought a new position in shares of The Allstate Corporation (NYSE:ALL) during the second quarter, HoldingsChannel.com reports. The firm bought 46,183 shares of the insurance provider’s stock, valued at approximately $10,989,000.

Several other hedge funds also recently made changes to their positions in ALL. Coldstream Capital Management Inc. boosted its stake in shares of Allstate by 0.6% in the fourth quarter. Coldstream Capital Management Inc. now owns 7,809 shares of the insurance provider’s stock valued at $1,625,000 after buying an additional 50 shares during the period. Compound Planning Inc. increased its stake in Allstate by 1.6% during the 4th quarter. Compound Planning Inc. now owns 3,216 shares of the insurance provider’s stock worth $669,000 after acquiring an additional 50 shares during the period. Cullen Frost Bankers Inc. raised its holdings in Allstate by 0.9% in the 4th quarter. Cullen Frost Bankers Inc. now owns 5,815 shares of the insurance provider’s stock valued at $1,210,000 after acquiring an additional 52 shares in the last quarter. Root Financial Partners LLC grew its holdings in shares of Allstate by 4.7% during the 1st quarter. Root Financial Partners LLC now owns 1,170 shares of the insurance provider’s stock worth $243,000 after purchasing an additional 53 shares in the last quarter. Finally, Montag A & Associates Inc. increased its position in shares of Allstate by 10.2% in the fourth quarter. Montag A & Associates Inc. now owns 596 shares of the insurance provider’s stock worth $125,000 after purchasing an additional 55 shares during the period. 76.47% of the stock is owned by institutional investors.

Trending Headlines about Allstate

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Zacks Research raised several Allstate EPS forecasts, including estimates for Q3 2026, FY2027, FY2028, Q1 2027, Q4 2027 and Q2 2028. Zacks maintains a “Strong-Buy” rating, supporting the view that underwriting performance and earnings power may remain resilient. Allstate earnings estimates
• Positive Sentiment: A Zacks screen identified ALL as a high-return-on-equity, cash-rich stock that could appeal to investors seeking quality and financial strength during volatile markets. High-ROE stocks article
• Neutral Sentiment: Allstate opened a new Dallas auto laboratory to train claims adjusters on increasingly complex vehicle technology. The initiative could improve claims accuracy and customer service over time, but it is unlikely to materially affect near-term earnings. Allstate Dallas auto lab
• Negative Sentiment: Keefe, Bruyette & Woods downgraded ALL from “hold” to “moderate sell,” adding to investor caution around the stock’s valuation and outlook. Allstate analyst downgrade
• Negative Sentiment: Allstate estimated July catastrophe losses of $682 million pretax, or $539 million after tax. The losses bring pretax catastrophe costs for the current aggregate year to approximately $2.402 billion, creating pressure on underwriting margins and near-term earnings. Allstate July 2026 monthly release
• Negative Sentiment: Zacks Research lowered its Q2 2027 and Q4 2026 EPS estimates, indicating that analysts still see some periods of earnings pressure despite upward revisions elsewhere. Allstate earnings estimates

Allstate Stock Performance

NYSE ALL opened at $253.82 on Friday. The firm’s fifty day moving average price is $250.34 and its two-hundred day moving average price is $224.95. The stock has a market cap of $64.18 billion, a PE ratio of 5.07, a PEG ratio of 0.39 and a beta of 0.16. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.36 and a current ratio of 0.36. The Allstate Corporation has a fifty-two week low of $188.08 and a fifty-two week high of $277.22.

Allstate (NYSE:ALL) last issued its quarterly earnings data on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share for the quarter, topping analysts’ consensus estimates of $6.06 by $2.93. The business had revenue of $18.60 billion for the quarter, compared to analyst estimates of $15.46 billion. Allstate had a return on equity of 41.64% and a net margin of 18.97%.Allstate’s quarterly revenue was up 11.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $5.94 EPS. On average, equities analysts expect that The Allstate Corporation will post 34.45 EPS for the current fiscal year.

Allstate Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Monday, August 31st will be given a dividend of $1.08 per share. The ex-dividend date is Monday, August 31st. This represents a $4.32 annualized dividend and a yield of 1.7%. Allstate’s dividend payout ratio (DPR) is currently 8.63%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. Morgan Stanley set a $265.00 price objective on shares of Allstate in a research report on Tuesday, August 11th. Roth Capital set a $300.00 target price on Allstate in a research note on Thursday, August 6th. Citigroup downgraded Allstate from a “neutral” rating to a “sell” rating and raised their target price for the company from $226.00 to $240.00 in a report on Tuesday, August 11th. The Goldman Sachs Group reiterated a “neutral” rating and issued a $280.00 price target on shares of Allstate in a research note on Friday, August 7th. Finally, Barclays boosted their price target on Allstate from $213.00 to $226.00 and gave the stock an “underweight” rating in a report on Thursday, August 6th. Four equities research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, eight have issued a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $265.26.

Insiders Place Their Bets

In other Allstate news, COO Mario Rizzo sold 56,225 shares of the company’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $264.48, for a total value of $14,870,388.00. Following the completion of the transaction, the chief operating officer directly owned 82,227 shares in the company, valued at approximately $21,747,396.96. This represents a 40.61% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider John E. Dugenske sold 32,996 shares of the firm’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $269.33, for a total transaction of $8,886,812.68. Following the transaction, the insider directly owned 13,054 shares of the company’s stock, valued at $3,515,833.82. The trade was a 71.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 91,446 shares of company stock valued at $24,208,675 in the last ninety days. 1.55% of the stock is currently owned by insiders.

About Allstate

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.